Results 191 to 200 of about 39,266 (270)

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.

JAMA Dermatol
Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB.   +11 more
europepmc   +1 more source

Spesolimab Treatment in GPP: Impact of IL-36RN Mutations and Concomitant Plaque Psoriasis. [PDF]

Clin Cosmet Investig Dermatol
Li W, Liang J, Luo Y, Chen S, Xia M, Ye H, Yang B, Luo Q.   +7 more
europepmc   +1 more source

Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report. [PDF]

SAGE Open Med Case Rep
Lozito A, Baravalle S, Poddine G, Colato C, Carletto A, Fracassi E, Bellinato F, Girolomoni G, Gisondi P.   +8 more
europepmc   +1 more source

Induced pemphigus erythematosus after treatment for plaque psoriasis with secukinumab: a case report. [PDF]

Front Immunol
Hu F, Peng H, Gong J, Tao X, Wang X, Bao J, He P, Dirwanto L, Liu M, Yang H.   +9 more
europepmc   +1 more source

Hepatotoxicity Induced by Adalimumab in Chronic Plaque Psoriasis Patient: A Case Report. [PDF]

Int Med Case Rep J
Algarzae NK, Alotaibi HM, Alajlan AH, AlSaleh MR, Alsalman AA.   +4 more
europepmc   +1 more source

Factors Predicting Guselkumab Treatment Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of Korean Real-World Data. [PDF]

J Clin Med
Lee YB, Shin BS, Kim M, Suh MK, Youn SW, Lee JY, Kim CW, Lee GY, Kim KH, An J, Kim Y, Kim KJ, Kim DH, Son SW.   +13 more
europepmc   +1 more source

Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report. [PDF]

Cureus
AlQusaimi R, AlRujaib F, AlSharhan F, AlAwadhi D, Alassaf S, Abdulrahman F.   +5 more
europepmc   +1 more source

Impact of treatment interruption on the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis: a <i>post-hoc</i> analysis of a phase 3 trial. [PDF]

Front Immunol
Li Q, Yao W, Lei D, Xu Y, Zhang L, Zhao Z, He J, Guo T, Li J.   +8 more
europepmc   +1 more source

Plaque psoriasis on the tongue: case report. [PDF]

An Bras Dermatol
Garcia LC, Schwan NV, Rosa Júnior JF, Ramos AMC.   +3 more
europepmc   +1 more source

Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis. [PDF]

Arthritis Rheumatol
Kerschbaumer A, Steiner M, Khalili S, Shehab A, Jordanov A, Wildner B, Maad M, Smolen JS, Aletaha D.   +8 more
europepmc   +1 more source